NTPC Q1 Results: Cons PAT rises 11% YoY to Rs 6,108 crore, revenue falls 3%
NTPC reported an 11% YoY rise in Q1FY26 net profit to Rs 6,108 crore, despite a 3% decline in revenue. Profit and revenue fell sequentially. The board set September 4 as the record date for a Rs 3.35/share final dividend.
Tilaknagar to raise Rs 2,296 crore via preferential issue for Imperial Blue buy
Tilaknagar Industries will raise ₹2,296 crore through a preferential issue of equity shares and warrants to fund its ₹4,150 crore acquisition of Imperial Blue whiskey from Pernod Ricard. The issue, priced at ₹382 per security, includes participation from promoters and institutional investors.
InterGlobe Aviation Q1 Results Preview: Indigo’s PAT likely to dip despite up to 9% revenue growth. Here’s why
IndiGo operator InterGlobe Aviation is expected to report lower Q1FY26 profitability despite 7–9% revenue growth. Weak load factors, soft yields, and higher operating costs may hurt margins. Analysts will watch for updates on grounded aircraft and overseas expansion.
NSDL IPO GMP at 17% ahead of tomorrow’s launch: Price band, key dates & other details
NSDL IPO: The price band for the NSDL IPO is set between ₹760 and ₹800 per equity share. At the upper end, the company aims to raise ₹4,011.6 crore through an offer for sale (OFS), with no fresh issue of shares.
HeidelbergCement India Q1 Results: Profit jumps 21% to Rs 48 crore, sales up 12%
HeidelbergCement India Ltd on Tuesday reported a 20.87 per cent rise in net profit to Rs 48.23 crore for the June quarter of FY26.
Aditya Infotech IPO GMP hints at 38% listing pop. Some brokerages say subscribe, others warn of risks
Aditya Infotech’s IPO opened with a bang, backed by a 38% grey market premium and strong retail demand. But while firms like Geojit and Reliance Securities recommend subscribing to long-term growth prospects, others, such as SBI Securities, flag high valuations and weak cash flows as red flags.
Only 2 equity mutual fund categories offer positive average returns in 1 month. Check details
In the past month, only international and pharma equity mutual fund categories showcased positive average returns. International funds led with a 4.18% return. Pharma funds followed closely, delivering 3.54% returns. However, these sectoral and thematic funds carry high risk.
NSDL IPO: 10 risks investors should be mindful of ahead of Wednesday’s launch
National Securities Depository’s IPO is ready to launch. The IPO size is Rs 4,011.6 crore. It will open for subscription soon. The company highlights potential risks in its prospectus. These risks include business hits and revenue concentration. Competition from CDSL is another concern. Regulatory changes and cybersecurity threats are also listed. Investors should consider these […]
FIIs on sidelines due to high valuations despite macro strength: Jitendra Gohil
Kotak Alternate Asset’s Jitendra Gohil anticipates heightened competition across Indian sectors due to government initiatives and reduced business costs, potentially pressuring earnings despite strong macro fundamentals. He advises investors to be selective, focusing on companies with strong management and the ability to acquire and turn around businesses. FIIs are hesitant due to high valuations, awaiting […]
Tata Motors shares down 42% from peak: Should you buy the dip in this auto major’s stock?
Tata Motors faces investor patience test as it trades at a significant discount. Technically range-bound, analysts suggest monitoring key levels for potential breakouts. JLR’s tariff relief offers a glimmer of hope, but margin concerns persist. The stock’s direction hinges on JLR’s performance and overcoming technical resistance, with cautious optimism for the festive season.